(1)
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies. J of Skin 2021, 5 (1), s8. https://doi.org/10.25251/skin.5.supp.8.